A5100327598- Myasthenia Gravis and Thymoma
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Thyroid and Parathyroid Surgery
- Metastasis and carcinoma case studies
- Parkinson's Disease and Spinal Disorders
- Pituitary Gland Disorders and Treatments
- Lung Cancer Research Studies
- Salivary Gland Tumors Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Dental Radiography and Imaging
- Dialysis and Renal Disease Management
- Neuroblastoma Research and Treatments
- Therapeutic Uses of Natural Elements
- Peripheral Neuropathies and Disorders
- Adrenal Hormones and Disorders
- Parathyroid Disorders and Treatments
- Dental Implant Techniques and Outcomes
- Dental Trauma and Treatments
Ocean University of China
2023
Sun Yat-sen University
2015-2022
The First Affiliated Hospital, Sun Yat-sen University
2015-2022
Fifth Hospital of Shijiazhuang
2020
Fifth Hospital In Wuhan
2015
Wuhan University
2015
The length of time for clinical improvement patients with thymomatous myasthenia gravis (MG) after extended thymectomy is not clear. purpose this study was to determine the in MG achieve a 3-point reduction Quantitative Myasthenia Gravis Score (QMGS), and identify variables associated failure reduction.The records who underwent from January 2005 December 2018 were retrospectively reviewed. primary end point 3 points QMGs secondary another QMGs.A total 481 included analysis, mean age 41.63 ±...
The goal of this study was to identify the relationship between clinical characteristics and occurrence postoperative myasthenia gravis (PMG) in patients with thymomas further PMG prognosis.Thymoma who had surgery at First Affiliated Hospital Sun Yat-sen University July 2004 2016 were reviewed those no previous symptoms selected for investigation. In total, 229 included study; their gathered analysed.Among patients, 19 (8.3%) PMG. time operation onset 134 days on average (range 2-730 days)....
Background The subxiphoid approach has been widely used recently. However, there is little data focusing on neurological outcomes in patients with thymomatous myasthenia gravis (MG) who underwent thoracoscopic thymectomy. purpose of this study was to compare the MG extended thymectomy a or transthoracic 1 year postoperatively. Methods records Masaoka stage I and II thymomas from January 2019 December 2020 tumor size less than 5 cm were retrospectively reviewed evaluated. Neurological...
Thymoma is a rare thymic tumor but the most common anterior mediastinal tumor. Currently, there are still limitations regarding to its screening and pathology remains elusive. In this study, nontargeted metabolomic analysis of serum was performed study metabolic characteristics thymoma using ultra-performance liquid chromatography—high resolution mass spectrometry (UPLC-HRMS) in positive negative ionization modes. The metabolites that were differentially abundant identified by MS/MS matching...
This study aimed to examine the expression of programmed cell death 1 ligand 2 (PD-L2) in thymoma and thymomatous myasthenia gravis (MG).The records 70 patients with receiving surgical resection between January 2017 December 2018 were retrospectively reviewed. Thymoma PD-L2 was evaluated by immunohistochemistry staining. Associations clinicopathologic features examined.PD-L2 positive 41 (58.6%) negative 29 (41.4%). Of them, 33 had MG. Patients MG more likely be 50 years age or younger...
Objective To analyze the influence of glass fibre post restoration on premolars fracture resistance with different numbers coronal dentin walls defect. Methods According to defect and methods, forty-eight mandibular first were randomly divided into six groups. Group A1: one-wall post-composite resin core restoration; A2: composite B1: two-wall B2: C1: three-wall C2: restoration. Every sample was loaded till failure by mechanical testing machine. The maximum loading value mode...
Abstract Purpose: The purpose of this study was to examine the expression PD-L2 in thymoma and thymomatous myasthenia gravis (MG). Methods: records 70 patients with who underwent surgical resection between January 2017 December 2018 were retrospectively reviewed. Thymoma evaluated by immunohistochemistry (IHC) staining. Associations clinicopathological features examined. Results: positive 41 (58.6%) negative 29 (41.4%). Of patients, 33 had MG. Patients MG more likely be ≤ 50 years age...
Abstract Background: The length of time for clinical improvement patients with thymomatous myasthenia gravis (MG) after extended thymectomy is not clear. purpose this study was to determine the in MG achieve a 3-point reduction Quantitative Myasthenia Gravis Score (QMGS), and identify variables associated failure reduction. Methods: records who underwent from January 2005 December 2018 were retrospectively reviewed. primary end point 3 points QMGs secondary another QMGs. Results: A total 481...